BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 24973918)

  • 1. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.
    Jo S; Yarishkin O; Hwang YJ; Chun YE; Park M; Woo DH; Bae JY; Kim T; Lee J; Chun H; Park HJ; Lee DY; Hong J; Kim HY; Oh SJ; Park SJ; Lee H; Yoon BE; Kim Y; Jeong Y; Shim I; Bae YC; Cho J; Kowall NW; Ryu H; Hwang E; Kim D; Lee CJ
    Nat Med; 2014 Aug; 20(8):886-96. PubMed ID: 24973918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.
    Wu Z; Guo Z; Gearing M; Chen G
    Nat Commun; 2014 Jun; 5():4159. PubMed ID: 24923909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease.
    Roy U; Stute L; Höfling C; Hartlage-Rübsamen M; Matysik J; Roβner S; Alia A
    Neurobiol Aging; 2018 Feb; 62():168-179. PubMed ID: 29154037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of motor coordination by astrocytic tonic GABA release through modulation of excitation/inhibition balance in cerebellum.
    Woo J; Min JO; Kang DS; Kim YS; Jung GH; Park HJ; Kim S; An H; Kwon J; Kim J; Shim I; Kim HG; Lee CJ; Yoon BE
    Proc Natl Acad Sci U S A; 2018 May; 115(19):5004-5009. PubMed ID: 29691318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.
    Park JH; Ju YH; Choi JW; Song HJ; Jang BK; Woo J; Chun H; Kim HJ; Shin SJ; Yarishkin O; Jo S; Park M; Yeon SK; Kim S; Kim J; Nam MH; Londhe AM; Kim J; Cho SJ; Cho S; Lee C; Hwang SY; Kim SW; Oh SJ; Cho J; Pae AN; Lee CJ; Park KD
    Sci Adv; 2019 Mar; 5(3):eaav0316. PubMed ID: 30906861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic urea cycle detoxifies Aβ-derived ammonia while impairing memory in Alzheimer's disease.
    Ju YH; Bhalla M; Hyeon SJ; Oh JE; Yoo S; Chae U; Kwon J; Koh W; Lim J; Park YM; Lee J; Cho IJ; Lee H; Ryu H; Lee CJ
    Cell Metab; 2022 Aug; 34(8):1104-1120.e8. PubMed ID: 35738259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amount of astrocytic GABA positively correlates with the degree of tonic inhibition in hippocampal CA1 and cerebellum.
    Yoon BE; Jo S; Woo J; Lee JH; Kim T; Kim D; Lee CJ
    Mol Brain; 2011 Nov; 4():42. PubMed ID: 22107761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 6 receptor controls Alzheimer's disease and depression.
    Yun HM; Park KR; Kim EC; Kim S; Hong JT
    Oncotarget; 2015 Sep; 6(29):26716-28. PubMed ID: 26449188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state.
    Bhalla M; Lee CJ
    Mol Brain; 2024 Jan; 17(1):3. PubMed ID: 38216963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bell-shaped dependence between amyloidosis and GABA accumulation in astrocytes in a mouse model of Alzheimer's disease.
    Brawek B; Chesters R; Klement D; Müller J; Lerdkrai C; Hermes M; Garaschuk O
    Neurobiol Aging; 2018 Jan; 61():187-197. PubMed ID: 29107186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Channel-mediated tonic GABA release from glia.
    Lee S; Yoon BE; Berglund K; Oh SJ; Park H; Shin HS; Augustine GJ; Lee CJ
    Science; 2010 Nov; 330(6005):790-6. PubMed ID: 20929730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.